After a very profitable decade on Microsoft's board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.
Source: TechCrunch — Venture — read the full report at the original publisher.

After a very profitable decade on Microsoft's board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.
After a very profitable decade on Microsoft's board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.
Source: TechCrunch — Venture — read the full report at the original publisher.
TechCrunch — Venture · View original